About
Founder and General Partner of Kern Capital, established in 2020 with a focus on life sciences. Previously founded Kern Whelan Capital (2007) and was Managing Director at Reynolds, DeWitt & Co., leading acquisitions and venture financings; earlier a management consultant at McKinsey. Holds a JD and MBA from the University of Chicago and a BA from Princeton.
Deals Β· 21
Latigo BiotherapeuticsSolo GP
via Kern Capital, LLC Β· filed Jan 2025
4J TherapeuticsSolo GP
via Kern Capital, LLC Β· filed Aug 2022
Lottery NowSolo GP
via Kern Capital, LLC Β· filed Nov 2019
Concentric AnalgesicsSolo GP
InvestCloudSolo GP
RiboscienceSolo GP
AIdentifiedSolo GP
Apton BiosystemsSolo GP
Arcadia CommunicationsSolo GP
DiscoviaSolo GP
GPN VaccinesSolo GP
IonetixSolo GP
ISISolo GP
Pallet Logistics of AmericaSolo GP
PGDxSolo GP
ProService HawaiiSolo GP
Provider SynergiesSolo GP
Reata PharmaceuticalsSolo GP
Shopatron Inc.Solo GP
Tab ProductsSolo GP
Tech LightingSolo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Where does Jay Kern work?
- Jay Kern is Founder and General Partner at Kern Capital, LLC.
